The plan of action of Biocon comprises of five key development verticals –
Small Molecules (APIs),
Biosimilars,
Branded Formulations,
Novel Molecules
Research Services.
All the five verticals are incorporated for development of the organization and furthermore help to cut the challenge
Biocon's completely coordinated plan of action traverses the whole medication esteem chain, from pre-clinical revelation to clinical improvement and through to commercialisation.
organizations in coordinated research administrations (Syngene) and marked definitions, little atoms and biologics (Biocon) give various income streams to adjust hazard, drive development, convey items and quicken development.
As they increment the intricacy and extent of our own R&D and assembling activities, particularly in new item disclosure and advancement, they accept custom and clinical research administrations will keep on offering significant cooperative energies
